XML 48 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Based Compensation - Schedule of Stock Options and SARs Transactions (Details) - Stock Options/SARs - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Number of Stock Options/SARs    
Beginning balance (in shares) 4,225 9,969
Granted (in shares) 0 2
Exercised (in shares) (924) (4,282)
Forfeited (in shares) (78) (192)
Ending balance (in shares) 3,223 5,497
Vested or Expected to Vest (in shares) 3,175 5,344
Exercisable (in shares) 2,646 3,686
Weighted Average Exercise Price    
Beginning balance (in USD per share) $ 77.49 $ 84.37
Granted (in USD per share) 0 97.64
Exercised (in USD per share) 76.88 91.63
Forfeited (in USD per share) 86.69 84.26
Ending balance (in USD per share) 77.45 78.73
Vested or Expected to Vest (in USD per share) 77.38 79.05
Exercisable (in USD per share) $ 76.53 $ 84.18
Additional Disclosures    
Intrinsic value of stock options/SARs exercised $ 46 $ 122
Intrinsic value of stock options/SARs outstanding $ 159 $ 194
Weighted average remaining contractual life for stock options/SARs outstanding (in years) 3 years 7 months 6 days 4 years 3 months 18 days
Intrinsic value of stock options/SARs vested or expected to vest $ 157 $ 187
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) 3 years 7 months 6 days 4 years 3 months 18 days
Aggregate intrinsic value for exercisable units $ 133 $ 114
Weighted average remaining contractual life for exercisable options/SARs (in years) 3 years 3 months 18 days 3 years 8 months 12 days